National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)

计划入组 28 人 · 首次发布于 2022 年 10 月 3 日

Retrospective Chart Review Study of Patients With PIK3CA-Related Overgrowth Spectrum Who Have Received Alpelisib

计划入组 57 人 · 首次发布于 2020 年 2 月 26 日

Health-related Quality of Life, Symptom Severity, and Pain Among Patients With PIK3CA-related Overgrowth Spectrum: A Mixed-methods Observational Study

计划入组 77 人 · 首次发布于 2022 年 3 月 24 日

PI3Kalpha inhibitors (PIK3CA-related overgrowth spectrum)

PIK3CA

STXBP1-Related Disorders(Encoded)

Alzheimer's Disease And Related Disorders Association, Inc.

United States

Alzheimer's Disease And Related Disorders Association, Georgia Chapter, Inc.

United States

SPECTRUM PHARMACEUTICALS, INC.

United States

EMA Grants Conditional Approval for Vijoice, First Treatment for Rare PIK3CA-Related Overgrowth Disorders

Gabather Initiates Phase II TOTEMS Trial for GT-002 in Schizophrenia Spectrum Disorders

Antipsychotics Show Limited Cognitive Benefits in Schizophrenia Spectrum Disorders